IQVIA Holdings Inc.

NYSE:IQV Stock Report

Market Cap: US$34.7b

IQVIA Holdings Past Earnings Performance

Past criteria checks 4/6

IQVIA Holdings has been growing earnings at an average annual rate of 34.8%, while the Life Sciences industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 7.7% per year. IQVIA Holdings's return on equity is 20.2%, and it has net margins of 9.2%.

Key information

34.8%

Earnings growth rate

35.9%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate7.7%
Return on equity20.2%
Net Margin9.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

IQVIA: Will This Beaten-Down Stock Bounce Back? 3 Things To Know

Dec 12

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Nov 14
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Oct 21
Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

IQVIA Holdings Inc.'s (NYSE:IQV) Business Is Trailing The Market But Its Shares Aren't

Sep 22
IQVIA Holdings Inc.'s (NYSE:IQV) Business Is Trailing The Market But Its Shares Aren't

IQVIA Holdings Inc. (NYSE:IQV) Shares Could Be 38% Below Their Intrinsic Value Estimate

Sep 08
IQVIA Holdings Inc. (NYSE:IQV) Shares Could Be 38% Below Their Intrinsic Value Estimate

Reiterating Buy On IQVIA After Q2 Earnings

Aug 20

With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

Aug 11
With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

Jul 30
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

These 4 Measures Indicate That IQVIA Holdings (NYSE:IQV) Is Using Debt Reasonably Well

Jul 18
These 4 Measures Indicate That IQVIA Holdings (NYSE:IQV) Is Using Debt Reasonably Well

An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 33% Undervalued

Jun 04
An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 33% Undervalued

IQVIA: Long-Term Compounder Throwing Off Free Cash Flow

May 27

Is It Time To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)?

Apr 24
Is It Time To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)?

Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?

Apr 11
Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?

IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Not Quite Adding Up

Mar 27
IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Not Quite Adding Up

Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors

Mar 14
Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors

IQVIA Holdings: Strong Q4 Results Suggest A Bullish 2024

Feb 22

Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Jan 23
Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

Dec 24
Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

IQVIA Q3: TAS Segment Remains The Problem Child

Nov 21

IQVIA: I Would Stay Away Until Debt Issues Are Resolved

Nov 12

IQVIA: Stock To Remain Rangebound As I Expect Weak Numbers In The Near Term

Sep 07

IQVIA Holdings Q2: Breaking Ground And Beating Expectations

Aug 03

IQVIA Holdings: A Possible Beat And Raise Scenario In The Works

May 23

IQVIA Q4 2022 Earnings Preview

Feb 09

IQVIA Holdings: Premium Valuation Is Justified For An Industry Leader

Jan 24

IQVIA Holdings Sees Digital Opportunities, But Debt Drags Growth

Nov 02

IQVIA Q3 2022 Earnings Preview

Oct 25

IQVIA: Rebound Is Likely But Downtrend Is Still Intact (Technical Analysis)

Sep 19

GSK, Iqvia launch Vaccine Track platform to highlight vaccine trends publicly in US

Aug 11

IQVIA: Resiliency And Quality Never Left, Q2 Earnings Evidence The Same

Jul 28

Revenue & Expenses Breakdown

How IQVIA Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:IQV Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2415,3151,4052,0850
30 Jun 2415,1551,4232,0650
31 Mar 2415,0691,3572,0380
31 Dec 2314,9841,3582,0430
30 Sep 2314,8551,1162,0470
30 Jun 2314,6811,0962,0620
31 Mar 2314,4941,0552,0630
31 Dec 2214,4101,0912,0380
30 Sep 2214,3071,1821,9970
30 Jun 2214,1361,1601,9780
31 Mar 2214,0331,0791,9770
31 Dec 2113,8749661,9310
30 Sep 2113,5367671,8860
30 Jun 2112,9316071,8480
31 Mar 2112,0144091,7970
31 Dec 2011,3592791,7620
30 Sep 2010,9561761,7590
30 Jun 2010,9391321,6940
31 Mar 2011,1582151,6990
31 Dec 1911,0881911,7110
30 Sep 1910,8812441,6690
30 Jun 1910,7062471,7030
31 Mar 1910,5332481,6910
31 Dec 1810,4122591,6920
30 Sep 1810,2451,2171,7380
30 Jun 1810,1171,2451,6990
31 Mar 189,9051,2461,6440
31 Dec 179,7021,2771,6050
30 Sep 179,133721,5280
30 Jun 177,804841,3450
31 Mar 176,6161081,1920
31 Dec 166,815721,0130
30 Sep 164,5403977610
30 Jun 164,4974097850
31 Mar 164,4044087950
31 Dec 154,3263878150
30 Sep 154,2623719020
30 Jun 154,2293528900
31 Mar 154,1913538830
31 Dec 144,1653577810
30 Sep 144,1063418900
30 Jun 143,9773158710
31 Mar 143,8862688800
31 Dec 133,8082278300

Quality Earnings: IQV has high quality earnings.

Growing Profit Margin: IQV's current net profit margins (9.2%) are higher than last year (7.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: IQV's earnings have grown significantly by 34.8% per year over the past 5 years.

Accelerating Growth: IQV's earnings growth over the past year (25.9%) is below its 5-year average (34.8% per year).

Earnings vs Industry: IQV earnings growth over the past year (25.9%) exceeded the Life Sciences industry -4.7%.

Return on Equity

High ROE: Whilst IQV's Return on Equity (20.17%) is high, this metric is skewed due to their high level of debt.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 06:06
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IQVIA Holdings Inc. is covered by 44 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Gregory BolanAvondale Partners
Eric ColdwellBaird